Documentos de Calpena A.C. | REDI

Regresar

Mostrando 6 resultados de: 6

Filtros aplicados

Palabras Claves: "Nanoparticles"

Subtipo de publicación

Publisher

International Journal of Pharmaceutics(1)

Journal of Nanobiotechnology(1)

Nanomaterials(1)

Nanomedicine: Nanotechnology, Biology, and Medicine(1)

Área temáticas

Farmacología y terapéutica(5)

Enfermedades(4)

Medicina y salud(4)

Cirugía y especialidades médicas afines(1)

Fisiología humana(1)

Área de conocimiento

Farmacología(5)

Biotecnología(2)

Biomateriales(1)

Descubrimiento de fármacos(1)

Año de Publicación

Origen

Palabras Claves

Alzheimer's disease(3)

Dexibuprofen(2)

APPswe/PS1dE9 mice(1)

Comparative study of Ex Vivo transmucosal permeation of pioglitazone nanoparticles for the treatment of Alzheimer's disease

Abstract: Pioglitazone has been reported in the literature to have a substantial role in the improvement of ov

Palabras claves:

Alzheimer's disease, Nanoparticles, Pioglitazone, PLGA-PEG, Transmucosal permeations

Calpena A.C., Espina M., García M.L., Halbaut L., Lupe Carolina Espinoza, Silva-Abreu M.

Article dexibuprofen biodegradable nanoparticles: One step closer towards a better ocular interaction study

Abstract: Ocular inflammation is one of the most prevalent diseases in ophthalmology, which can affect various

Palabras claves:

Dexibuprofen, Drug delivery system, Nanoparticles, PLGA

Alsafi Z., Antoni Camins, Calpena A.C., Cano A., Espina M., Esteruelas G., Ettcheto M., García M.L., Muñoz M., Ortiz A., Prat J., Pujol M., Sanchez-Lopez E., Souto E.M.B.

New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9

Abstract: Dexibuprofen loaded pegylated poly(lactic-co-glycolic) nanospheres prepared by solvent diffusion met

Palabras claves:

Alzheimer's disease, Blood–Brain barrier, Dexibuprofen, Nanoparticles, Nanospheres, PLGA-PEG

Antoni Camins, Calpena A.C., Egea M.A., Espina M., Ettcheto M., Folch J., García M.L., Sanchez-Lopez E.

In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration

Abstract: Pranoprofen (PF) is a NSAID considered as a safe anti-inflammatory treatment for strabismus and/or c

Palabras claves:

Anti-inflammatory efficacy, Corneal permeation, Cytotoxicity cell, Nanoparticles, Poly (lactic/glycolic) acid (PLGA), Pranoprofen

Abrego G., Alvarado H., Calpena A.C., Cristina Cañadas, García M.L., Silva A.M., Souto E.M.B.

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: In vitro and in vivo characterization

Abstract: Background: Memantine, drug approved for moderate to severe Alzheimer's disease, has not shown to be

Palabras claves:

Alzheimer's disease, APPswe/PS1dE9 mice, astrocytes, BEnd.3, Brain targeting, Memantine, Nanoparticles, β-Amyloid plaques

Antoni Camins, Calpena A.C., Cano A., Carmona N., Egea M.A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Silva A.M., Souto E.M.B.

Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma

Abstract: Glaucoma is a multifactorial neurodegenerative disease associated with retinal ganglion cells (RGC)

Palabras claves:

drug delivery, glaucoma, Memantine, Nanoparticles, PLGA-PEG

Antoni Camins, Calpena A.C., Cordeiro M.F., Davis B.M., Egea M.A., Espina M., Ettcheto M., García M.L., Guo L., Ravindran N., Sanchez-Lopez E., Silva A.M., Souto E.M.B.